Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.10.5251

Is the MDR1 C3435T Polymorphism Responsible for Oral Mucositis in Children with Acute Lymphoblastic Leukemia?  

Bektas-Kayhan, Kivanc (Department of Oral Surgery and Medicine, Faculty of Dentistry, Istanbul University)
Kucukhuseyin, Ozlem (Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University)
Karagoz, Gizem (Department of Oral Surgery and Medicine, Faculty of Dentistry, Istanbul University)
Unur, Meral (Department of Oral Surgery and Medicine, Faculty of Dentistry, Istanbul University)
Ozturk, Oguz (Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University)
Unuvar, Aysegul (Department of Pediatric Hematology and Oncology, Faculty of Medicine, Istanbul University)
Devecioglu, Omer (Department of Pediatric Hematology and Oncology, Faculty of Medicine, Istanbul University)
Yilmaz-Aydogan, Hulya (Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.10, 2012 , pp. 5251-5255 More about this Journal
Abstract
Background and Aim: Although the functional consequences of MDR-1 polymorphisms have been the subject of numerous studies, to the best to our knowledge, associations with clinical side effects of anticancer drugs have yet to be assessed. Our aim was to clarify any role of the C3435T polymorphism of the MDR1 gene in oral mucositis and its relation with elevated reactive oxygen species (ROS) levels, in children with acute lymphoblastic leukemia (ALL). Materials and Methods: The distribution of the MDR-1 C3435T polymorphism in 47 patients with ALL was determined by RFLP and compared with that of 68 healthy controls. Results: There were no association in distribution of genotypes of MDR-1 C3435T polymorphism and the risk of ALL. Oral mucositis were detected in 78.7% (n=37) of the patients and significantly related to the MDR-1 CT genotype (p=0.042), as confirmed by logistic regression analysis. Conclusion: Our preliminary data suggest that children carrying the CT genotype are more prone to develop oral mucositis, which might mean that the heterozygous genotype leads to accumulation of more reactive oxygen species. Since a limited number of patients was investigated, further studies are needed to confirm these findings.
Keywords
MDR-1 C3435T polymorphism; acute lymphoblastic leukemia; oral mucositis; reactive oxygen species;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Aladjidi N, Auvrignon A, Leblanc T, et al (2003). Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of pediatric hematology and immunology. J Clin Oncol, 21, 4377-85.   DOI
2 Bradley G, Juranka PF, Ling V (1988). Mechanisms of multidrug resistance. Biochim Biophys Acta, 948, 87-128.
3 Cascorbi I, Gerloff T, Johne A, et al (2001). Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in White subjects. Clin Pharmacol Ther, 69, 169-74.   DOI   ScienceOn
4 Cascorbi I, Gerloff T, Johne A, et al (2001). Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in White subjects. Clin Pharmacol Ther, 69, 169-74.   DOI   ScienceOn
5 Chong AS, Markham PN, Gebel HM, Bines SD, Coon JS (1995). Diversemultidrugresistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother, 36, 133-9.
6 Drach J, Gsur A, Hamilton G, et al (1996). Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-g in normal human T lymphocytes. Blood, 88, 1747-54.
7 Drach J, Gsur A, Hamilton G, et al (1996). Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-g in normal human T lymphocytes. Blood, 88, 1747-54.
8 Goldstein LJ, Galski H, Fojo A, et al (1989). Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst, 81, 116-24.   DOI
9 Greaves M (2006). Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer, 6, 193-203.   DOI
10 Gupta S, KimCH, Tsuruo T, Gollapudi S (1992). Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol, 12, 451-8.   DOI
11 Hitzl M, Drescher S, Van der Kuip H, et al (2001). The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics, 11, 293-8.   DOI   ScienceOn
12 Hoffmeyer S, Burk O, Von Richter O, et al (2000). Functional polymorphisms of the human multidrug resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 97, 3473-8.   DOI
13 Kroetz DL, Pauli-Magnus C, Hodges LM, et al (2003). Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics, 13, 481-94.   DOI   ScienceOn
14 Illmer T, Schuler US, Thiede C, et al (2002). MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res, 62, 4955-62.
15 Jamroziak K, Mlynarski W, Balcerczak E, et al (2004). Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol, 72, 314-21.   DOI
16 Kim RB, Leake BF, Choo EF, et al (2001). Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther, 70, 189-99.   DOI   ScienceOn
17 Lin JH, Yamazaki M (2003). Role of p-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet, 42, 59-98.   DOI
18 Liscovitch M, Lavie Y (2002). Cancer multidrug resistance: a review of recent drug discovery research. IDrugs, 5, 349-55.
19 Miladpour B, Shokouhi AM, Shirdel A, et al (2009). Association of acute lymphoblastic leukemia and MDR1 gene polymorphism in an ethnic Iranian population. IJBC, 2, 63-7.
20 Miller SA, Dykes DD, Polesky HF (1998). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215.
21 Nakamura T, Sakaeda T, Horinouchi M, et al (2002). Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther, 71, 297-303.   DOI   ScienceOn
22 Rao DN, Anuradha C, Vishnupriya S, et al (2010). Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. Asian Pac J Cancer Prev, 11, 1063-66.
23 Pawlik A, Baskiewicz-Masiuk M, Machalinski B, Kurzawski M, Gawronska-Szklarz B (2005). Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol, 528, 27-36.   DOI
24 Pinto LP, Souza LB, Gordon-Nunez MA, et al (2006). Prevention of oral lesions in children with acute lymphoblastic leukemia. Int J Pediatric Otorhinolaryngol, 70, 1847-51.   DOI
25 Pui CH, Schrappe M, Ribeiro R, Niemeyer CM (2004). Childhood and adolescent lymphoid and myeloid leukemia. Hematology Am Soc Hematol Educ Program, 1, 118-45.
26 Sakaeda T, Nakamura T, Okumura K (2002). MDR1 genotyperelated pharmacokinetics and pharmacodynamics. Biol Pharm Bull, 25, 1391-400.   DOI
27 Sandler DP, Ross JA (1997). Epidemiology of acute leukemia in children and adults. Semin Oncol, 24, 3-16.
28 Schinkel AH (1997). The physiological function of drugtransporting P-glycoproteins. Semin Cancer Biol, 8, 161-70.   DOI   ScienceOn
29 Schinkel AH (1997). The physiological function of drugtransporting P-glycoproteins. Semin Cancer Biol, 8, 161-70.   DOI   ScienceOn
30 Siegsmung M, Brinkmann U, Scheffeler E, et al (2002). Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol, 13, 1847-54.   DOI   ScienceOn
31 Sills GJ, Mohanraj R, Butler E, et al (2005). Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46, 643-47.   DOI
32 Sonis ST (2011). Oral mucositis. Anticancer Drugs, 22, 607-12.   DOI
33 Tanabe M, Ieiri I, Nagata N, et al (2001). Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther, 297, 1137-43.
34 Tanabe M, Ieiri I, Nagata N, et al (2001). Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther, 297, 1137-43.
35 Vijayakrishnan J, Houlston RS (2010). Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica, 95, 1405-14.   DOI
36 Wang J, Wang B, Bi J, Li K, Di J (2012). MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 39 casecontrol studies. J Cancer Res Clin Oncol, 138, 979-89.   DOI
37 Wartenberg M, Hoffmann E, Schwindt H, et al (2005). Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids. FEBS Lett, 579, 4541-9.   DOI